AcouSort
4.82 SEK
-3.41 %
Less than 1K followers
ACOU
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-3.41 %
+58.03 %
+79.18 %
+70.32 %
+80.52 %
+51.10 %
-69.56 %
-80.84 %
-38.92 %
AcouSort operates in the medical technology sector. The company has a developed platform technology focused on acoustophoresis, which uses ultrasound to separate and analyze the compositions of biological cells. The technology is mainly used in the analysis of cancer cases and sepsis (blood poisoning). A large part of the research is carried out in collaboration with other players in Life Science. The company was established in 2010 and has its headquarters in Lund.
Read moreMarket cap
102.01M SEK
Turnover
428.85K SEK
Revenue
6.85M
EBIT %
-159.39 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.5
2026
Interim report Q1'26
18.6
2026
General meeting '26
26.8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
AcouSort sell an AcouTrap system to The Hebrew University of Jerusalem.
AcouSort’s technology exhibited together with Moeller Medical’s system at Analytica
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools